Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Stabilizers Used in Antibody Drugs and Vaccines market size was valued at USD 390.33 Million in 2022 and will reach USD 324.73 Million in 2028, with a CAGR of -3.02% during 2022-2028.
Antibodies are Y-shaped proteins produced by the body as part of the normal immune response to foreign molecules. Molecules from invading organisms - such as viruses, bacteria and other harmful organisms - are called "antigens" and prompt the body's B cells to produce billions of antibodies. Each antibody has two antigen-binding sites (one on each arm of Y) that can neutralize these invaders. Antibody drugs are based on key principles of biology, mimicking the body's and immune system's natural defenses and pathways. Scientists study how antibodies work to replicate and optimize for specific disease targets. Antibody drugs can now be made in the lab and given to people who need them for specific medical purposes.
Drivers
Vaccines are known to lose potency over time, especially when stored in suboptimal conditions such as ambient or warm temperatures. Since vaccines are often used in developing countries where it is difficult to maintain optimal storage conditions, there is a great need to develop methods in which the ability of vaccine compositions to elicit a protective immune response in a subject does not diminish over time. Great improvements in stability and shelf life have been achieved for various vaccine compositions. There are mainly two strategies used to improve stability. First, low temperature storage (eg -10 to -70 degrees Celsius) has been used, but maintaining such temperatures is often not feasible, especially in developing countries. The second method is to freeze-dry (freeze-dry) and reconstitute it into a liquid form before use. However, lyophilized vaccine compositions also lose efficacy over time. Furthermore, in both strategies, further improvements have been achieved by adding one or more stabilizers to the vaccine composition. In developing countries where it is difficult to maintain optimal storage conditions, the availability and development of stabilizers has made vaccine rollout more accessible. This drives the development of the industry.
With the improvement of economic level, people's living standards improve, and per capita disposable income also increases. In general, higher per capita income allows people to buy more goods and services, increase access to education, and increase access to health care. On the other hand, with the improvement of education level and the development of the Internet, people's health awareness is also increasing. Various factors have contributed to the growing market for various vaccines and antibody drugs. Growth in the downstream market is driving the growth of the Stabilizers Used in Antibody Drugs and Vaccines market.
Region Overview:
USA had the highest growth rate of all regions.
Company Overview:
Roquette Pharma is one of the major players operating in the Stabilizers Used in Antibody Drugs and Vaccines market, holding a share of 16.19% in 2022.
Segmentation Overview:
Among different product types, Sugars segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Vaccines segment occupied the biggest share from 2017 to 2022.
The Stabilizers Used in Antibody Drugs and Vaccines market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Stabilizers Used in Antibody Drugs and Vaccines market covered in Chapter 4:
Basf Se
Well Pharmaceutical
P&G Chemicals
Evonik Industries Ag
The Dow Chemical Company
Roquette Pharma
Ashland, Inc.
Poly Pharmaceutical
Wacker Chemie AG
JRS Pharma
In Chapter 12 and Chapter 14.1, on the basis of types, the Stabilizers Used in Antibody Drugs and Vaccines market from 2018 to 2028 is primarily split into:
Amino Acids
Sugars
Proteins
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Stabilizers Used in Antibody Drugs and Vaccines market from 2018 to 2028 covers:
Antibody Drugs
Vaccines
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Stabilizers Used in Antibody Drugs and Vaccines market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Stabilizers Used in Antibody Drugs and Vaccines market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Stabilizers Used in Antibody Drugs and Vaccines industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Stabilizers Used in Antibody Drugs and Vaccines industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Stabilizers Used in Antibody Drugs and Vaccines market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Stabilizers Used in Antibody Drugs and Vaccines market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Stabilizers Used in Antibody Drugs and Vaccines market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Stabilizers Used in Antibody Drugs and Vaccines market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
Antibodies are Y-shaped proteins produced by the body as part of the normal immune response to foreign molecules. Molecules from invading organisms - such as viruses, bacteria and other harmful organisms - are called "antigens" and prompt the body's B cells to produce billions of antibodies. Each antibody has two antigen-binding sites (one on each arm of Y) that can neutralize these invaders. Antibody drugs are based on key principles of biology, mimicking the body's and immune system's natural defenses and pathways. Scientists study how antibodies work to replicate and optimize for specific disease targets. Antibody drugs can now be made in the lab and given to people who need them for specific medical purposes.
Drivers
Vaccines are known to lose potency over time, especially when stored in suboptimal conditions such as ambient or warm temperatures. Since vaccines are often used in developing countries where it is difficult to maintain optimal storage conditions, there is a great need to develop methods in which the ability of vaccine compositions to elicit a protective immune response in a subject does not diminish over time. Great improvements in stability and shelf life have been achieved for various vaccine compositions. There are mainly two strategies used to improve stability. First, low temperature storage (eg -10 to -70 degrees Celsius) has been used, but maintaining such temperatures is often not feasible, especially in developing countries. The second method is to freeze-dry (freeze-dry) and reconstitute it into a liquid form before use. However, lyophilized vaccine compositions also lose efficacy over time. Furthermore, in both strategies, further improvements have been achieved by adding one or more stabilizers to the vaccine composition. In developing countries where it is difficult to maintain optimal storage conditions, the availability and development of stabilizers has made vaccine rollout more accessible. This drives the development of the industry.
With the improvement of economic level, people's living standards improve, and per capita disposable income also increases. In general, higher per capita income allows people to buy more goods and services, increase access to education, and increase access to health care. On the other hand, with the improvement of education level and the development of the Internet, people's health awareness is also increasing. Various factors have contributed to the growing market for various vaccines and antibody drugs. Growth in the downstream market is driving the growth of the Stabilizers Used in Antibody Drugs and Vaccines market.
Region Overview:
USA had the highest growth rate of all regions.
Company Overview:
Roquette Pharma is one of the major players operating in the Stabilizers Used in Antibody Drugs and Vaccines market, holding a share of 16.19% in 2022.
Segmentation Overview:
Among different product types, Sugars segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Vaccines segment occupied the biggest share from 2017 to 2022.
The Stabilizers Used in Antibody Drugs and Vaccines market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Stabilizers Used in Antibody Drugs and Vaccines market covered in Chapter 4:
Basf Se
Well Pharmaceutical
P&G Chemicals
Evonik Industries Ag
The Dow Chemical Company
Roquette Pharma
Ashland, Inc.
Poly Pharmaceutical
Wacker Chemie AG
JRS Pharma
In Chapter 12 and Chapter 14.1, on the basis of types, the Stabilizers Used in Antibody Drugs and Vaccines market from 2018 to 2028 is primarily split into:
Amino Acids
Sugars
Proteins
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Stabilizers Used in Antibody Drugs and Vaccines market from 2018 to 2028 covers:
Antibody Drugs
Vaccines
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Stabilizers Used in Antibody Drugs and Vaccines market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Stabilizers Used in Antibody Drugs and Vaccines market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Stabilizers Used in Antibody Drugs and Vaccines industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Stabilizers Used in Antibody Drugs and Vaccines industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Stabilizers Used in Antibody Drugs and Vaccines market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Stabilizers Used in Antibody Drugs and Vaccines market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Stabilizers Used in Antibody Drugs and Vaccines market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Stabilizers Used in Antibody Drugs and Vaccines market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
